US Stock MarketDetailed Quotes

ITCI Intra-Cellular Therapies

Watchlist
  • 66.840
  • +1.130+1.72%
Close May 15 16:00 ET
7.06BMarket Cap-57620P/E (TTM)

Intra-Cellular Therapies Key Stats

Intra-Cellular Therapies Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 7, 2024

Revenue(YoY)

144.87M

+52.00%
EPS(YoY)

-0.16

+65.22%

Strong Buy

May 8, 2024

Intra-Cellular Therapies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 13 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 171.808M--
--2024/Q2-- / 158.819M--
May 7, 20242024/Q1144.866M / 141.444M--
Feb 22, 20242023/Q4132.099M / 135.668M--
Nov 2, 20232023/Q3126.173M / 119.228M--
Aug 3, 20232023/Q2110.792M / 106.815M--
May 4, 20232023/Q195.306M / 92.413M--
Mar 1, 20232022/Q487.869M / 86.966M--
Nov 3, 20222022/Q371.870M / 66.004M--
Aug 9, 20222022/Q255.579M / 48.625M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 171.808M--
--2024/Q2-- / 158.819M--
May 7, 20242024/Q1144.866M / 141.444M--
Feb 22, 20242023/Q4132.099M / 135.668M--
Nov 2, 20232023/Q3126.173M / 119.228M--
Aug 3, 20232023/Q2110.792M / 106.815M--
May 4, 20232023/Q195.306M / 92.413M--
Mar 1, 20232022/Q487.869M / 86.966M--
Nov 3, 20222022/Q371.870M / 66.004M--
Aug 9, 20222022/Q255.579M / 48.625M--

Unlock Free Earnings Estimates

Intra-Cellular Therapies Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 8, 2024

Strong Buy

  • Buy

    91.67%
  • Hold

    8.33%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg